ATLANTA — The Blue-Ribbon Committee on medical cannabis conducted its fourth and final meeting Friday.

Dr. Elizabeth McCord, trained in internal medicine and psychiatry, has concerns about raising THC concentration and regulating product quality.

“It could be possible to use small amounts of THC for certain indications that are FDA approved, and that can be for an older population in a retirement community,” Dr. McCord says.

Lawmakers will make recommendations on any changes to the state’s medical marijuana and hemp products ahead of January’s legislative session.

“We’re seeing in the families, that these young kids are seeing their parents take medical cannabis and they’re associating cannabis with medicine,” said Dr. McCord. “Doctors prescribe medicine, and medicine is meant to help. The word can be misleading because its not a medicine.”